Systacare Remedies

You Tube Google Plus Facebook


Ceftriaxone Tazobactam Injection

Ceftriaxone Tazobactam Injection

Ceftriaxone Tazobactam Injection is formulated to conquer stubborn pathogens. The extensively recommended Ceftriaxone Tazobactam Injection has unmatched stability to beta-lactamases. Ceftriaxone 1000 mg / 500 mg / 250 mg + Tazobactam 125 mg / 62.5 mg / 31.25 mg Injection is meant for Im / IV use.

The Combined Attack of Two Synergistic Antibacterials In management of severe & Resistant infections :

  • Promises synergistic action of bactericidal ceftriaxone and betalactamase inhibitor Tazobactam
  • Provides broader anti-bacterial coverage
    • Tazobactam inhibits betalactamase producing bacteria & helps to incrase the spectrum of ceftriaxone
  • Achieves high conc. In CSF & tissue fluids
  • Highly effective against gram + ve, Gram – Ve bacteria & anaerobes
  • Ensures effective and safe treatment option in severe infections

 
Dosage And Administration :

  • Pediatric Patients  : Serious infections, 50-75 mg/kg (in terms of ceftriaxone) given in divided doses every 12 hours. The total daily dose should not exceed 2 gm (in terms of ceftriaxone). For the treatment of acute bacterial otitis media, a single 50 mg/kg IM (not to exceed 1 gram)
  • Adults  : 1000/125 mg of ceftriaxone / tazobactam OD (or in equally divided doses BID) total daily dose should not exceed 4 gm (in terms of ceftriaxone). For pre-operative use / surgical prophylaxis, 1gm I.V administered ½ to 2 hours before surgery for 4-14 days by deep IM, or slow IV


Indicated In :

  • Respiratory Tract Infection
  • Intrabdominal infections
    • Peritonitis,
    • Cholecystitis,
    • Cholangitis
  • Gynaecological Infections
  • - Endometritis,
  • - Gonorrhoea, - PID
  • Surgical Infections
  • Skin & Soft Tissue Infections
  • Sexually transmitted Diseases
  • Meningitis
  • Nosocomial infections
  • Bone & joint infections